Scopoletin Protects against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-Glycation
Recently, several types of foods and drinks, including coffee, cream, and cake, have been found to result in high methylglyoxal (MG) levels in the plasma, thus causing both nutritional and health concerns. MG can be metabolized by phase-II enzymes in liver through the positive regulation of nuclear...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2015-02-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | http://www.mdpi.com/1420-3049/20/2/2786 |
| _version_ | 1811314618720583680 |
|---|---|
| author | Wen-Chang Chang Shinn-Chih Wu Kun-Di Xu Bo-Chieh Liao Jia-Feng Wu An-Sheng Cheng |
| author_facet | Wen-Chang Chang Shinn-Chih Wu Kun-Di Xu Bo-Chieh Liao Jia-Feng Wu An-Sheng Cheng |
| author_sort | Wen-Chang Chang |
| collection | DOAJ |
| description | Recently, several types of foods and drinks, including coffee, cream, and cake, have been found to result in high methylglyoxal (MG) levels in the plasma, thus causing both nutritional and health concerns. MG can be metabolized by phase-II enzymes in liver through the positive regulation of nuclear factor-erythroid 2-related factor 2 (Nrf2). In this study, we investigated the ability of scopoletin (SP) to protect against MG-induced hyperglycemia and insulin resistance. Recently, SP was shown to be a peroxisome proliferator-activated receptor-γ activator to elevate insulin sensitivity. We investigated the effects of oral administration of SP on the metabolic, biochemical, and molecular abnormalities characteristic of type 2 diabetes in MG-treated Wistar rats to understand the potential mechanism of scopoletin for diabetes protection. Our results suggested that SP activated Nrf2 by Ser40 phosphorylation, resulting in the metabolism of MG into d-lactic acid and the inhibition of AGEs generation, which reduced the accumulation of AGEs in the livers of MG-induced rats. In this manner, SP improved the results of the oral glucose tolerance test and dyslipidemia. Moreover, SP also increased the plasma translocation of glucose transporter-2 and promoted Akt phosphorylation caused by insulin treatment in MG-treated FL83B hepatocytes. In contrast, SP effectively suppressed protein tyrosine phosphatase 1B (PTP1B) expression, thereby alleviating insulin resistance. These findings suggest that SP acts as an anti-glycation and anti-diabetic agent, and thus has therapeutic potential for the prevention of diabetes. |
| first_indexed | 2024-04-13T11:14:27Z |
| format | Article |
| id | doaj.art-8a92d49cb9fb470bafc7731c07eff974 |
| institution | Directory Open Access Journal |
| issn | 1420-3049 |
| language | English |
| last_indexed | 2024-04-13T11:14:27Z |
| publishDate | 2015-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Molecules |
| spelling | doaj.art-8a92d49cb9fb470bafc7731c07eff9742022-12-22T02:49:01ZengMDPI AGMolecules1420-30492015-02-012022786280110.3390/molecules20022786molecules20022786Scopoletin Protects against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-GlycationWen-Chang Chang0Shinn-Chih Wu1Kun-Di Xu2Bo-Chieh Liao3Jia-Feng Wu4An-Sheng Cheng5Department of Medicinal Plant Development, Yupintang Traditional Chinese Medicine Foundation, 4F., No.2, Ln. 138, Yongyuan Rd., Yonghe Dist., New Taipei City 234, TaiwanDepartment of Animal Science and Technology, National Taiwan University, 59 Roosevelt Road Section 4, Taipei 10617, TaiwanDepartment of Medicinal Plant Development, Yupintang Traditional Chinese Medicine Foundation, 4F., No.2, Ln. 138, Yongyuan Rd., Yonghe Dist., New Taipei City 234, TaiwanDepartment of Medicinal Plant Development, Yupintang Traditional Chinese Medicine Foundation, 4F., No.2, Ln. 138, Yongyuan Rd., Yonghe Dist., New Taipei City 234, TaiwanDepartment of Medicinal Plant Development, Yupintang Traditional Chinese Medicine Foundation, 4F., No.2, Ln. 138, Yongyuan Rd., Yonghe Dist., New Taipei City 234, TaiwanDepartment of Medicinal Plant Development, Yupintang Traditional Chinese Medicine Foundation, 4F., No.2, Ln. 138, Yongyuan Rd., Yonghe Dist., New Taipei City 234, TaiwanRecently, several types of foods and drinks, including coffee, cream, and cake, have been found to result in high methylglyoxal (MG) levels in the plasma, thus causing both nutritional and health concerns. MG can be metabolized by phase-II enzymes in liver through the positive regulation of nuclear factor-erythroid 2-related factor 2 (Nrf2). In this study, we investigated the ability of scopoletin (SP) to protect against MG-induced hyperglycemia and insulin resistance. Recently, SP was shown to be a peroxisome proliferator-activated receptor-γ activator to elevate insulin sensitivity. We investigated the effects of oral administration of SP on the metabolic, biochemical, and molecular abnormalities characteristic of type 2 diabetes in MG-treated Wistar rats to understand the potential mechanism of scopoletin for diabetes protection. Our results suggested that SP activated Nrf2 by Ser40 phosphorylation, resulting in the metabolism of MG into d-lactic acid and the inhibition of AGEs generation, which reduced the accumulation of AGEs in the livers of MG-induced rats. In this manner, SP improved the results of the oral glucose tolerance test and dyslipidemia. Moreover, SP also increased the plasma translocation of glucose transporter-2 and promoted Akt phosphorylation caused by insulin treatment in MG-treated FL83B hepatocytes. In contrast, SP effectively suppressed protein tyrosine phosphatase 1B (PTP1B) expression, thereby alleviating insulin resistance. These findings suggest that SP acts as an anti-glycation and anti-diabetic agent, and thus has therapeutic potential for the prevention of diabetes.http://www.mdpi.com/1420-3049/20/2/2786scopoletin (SP)methylglyoxal (MG)advanced glycation endproducts (AGEs)nuclear factor-erythroid 2-related factor 2 (Nrf2)anti-glycation |
| spellingShingle | Wen-Chang Chang Shinn-Chih Wu Kun-Di Xu Bo-Chieh Liao Jia-Feng Wu An-Sheng Cheng Scopoletin Protects against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-Glycation Molecules scopoletin (SP) methylglyoxal (MG) advanced glycation endproducts (AGEs) nuclear factor-erythroid 2-related factor 2 (Nrf2) anti-glycation |
| title | Scopoletin Protects against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-Glycation |
| title_full | Scopoletin Protects against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-Glycation |
| title_fullStr | Scopoletin Protects against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-Glycation |
| title_full_unstemmed | Scopoletin Protects against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-Glycation |
| title_short | Scopoletin Protects against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-Glycation |
| title_sort | scopoletin protects against methylglyoxal induced hyperglycemia and insulin resistance mediated by suppression of advanced glycation endproducts ages generation and anti glycation |
| topic | scopoletin (SP) methylglyoxal (MG) advanced glycation endproducts (AGEs) nuclear factor-erythroid 2-related factor 2 (Nrf2) anti-glycation |
| url | http://www.mdpi.com/1420-3049/20/2/2786 |
| work_keys_str_mv | AT wenchangchang scopoletinprotectsagainstmethylglyoxalinducedhyperglycemiaandinsulinresistancemediatedbysuppressionofadvancedglycationendproductsagesgenerationandantiglycation AT shinnchihwu scopoletinprotectsagainstmethylglyoxalinducedhyperglycemiaandinsulinresistancemediatedbysuppressionofadvancedglycationendproductsagesgenerationandantiglycation AT kundixu scopoletinprotectsagainstmethylglyoxalinducedhyperglycemiaandinsulinresistancemediatedbysuppressionofadvancedglycationendproductsagesgenerationandantiglycation AT bochiehliao scopoletinprotectsagainstmethylglyoxalinducedhyperglycemiaandinsulinresistancemediatedbysuppressionofadvancedglycationendproductsagesgenerationandantiglycation AT jiafengwu scopoletinprotectsagainstmethylglyoxalinducedhyperglycemiaandinsulinresistancemediatedbysuppressionofadvancedglycationendproductsagesgenerationandantiglycation AT anshengcheng scopoletinprotectsagainstmethylglyoxalinducedhyperglycemiaandinsulinresistancemediatedbysuppressionofadvancedglycationendproductsagesgenerationandantiglycation |